AU7009387A - Membrane proteoglycans ribosomal vaccines - Google Patents

Membrane proteoglycans ribosomal vaccines

Info

Publication number
AU7009387A
AU7009387A AU70093/87A AU7009387A AU7009387A AU 7009387 A AU7009387 A AU 7009387A AU 70093/87 A AU70093/87 A AU 70093/87A AU 7009387 A AU7009387 A AU 7009387A AU 7009387 A AU7009387 A AU 7009387A
Authority
AU
Australia
Prior art keywords
membrane proteoglycans
proteoglycans
ribosomal
vaccines
ribosomal vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70093/87A
Other languages
English (en)
Inventor
Lucien Dussourd D'hinterland
Jacques Durand
Gerard Normier
Anne-Marie Pinel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU7009387A publication Critical patent/AU7009387A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU70093/87A 1986-03-18 1987-03-17 Membrane proteoglycans ribosomal vaccines Abandoned AU7009387A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8603829 1986-03-18
FR8603829A FR2596064B1 (fr) 1986-03-18 1986-03-18 Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus

Publications (1)

Publication Number Publication Date
AU7009387A true AU7009387A (en) 1987-09-24

Family

ID=9333224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70093/87A Abandoned AU7009387A (en) 1986-03-18 1987-03-17 Membrane proteoglycans ribosomal vaccines

Country Status (8)

Country Link
EP (1) EP0238407B1 (enrdf_load_stackoverflow)
JP (1) JPH01124396A (enrdf_load_stackoverflow)
AT (1) ATE79037T1 (enrdf_load_stackoverflow)
AU (1) AU7009387A (enrdf_load_stackoverflow)
DE (1) DE3780843T2 (enrdf_load_stackoverflow)
ES (1) ES2051759T3 (enrdf_load_stackoverflow)
FR (1) FR2596064B1 (enrdf_load_stackoverflow)
GR (1) GR3005567T3 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739382B1 (fr) * 1995-09-28 1997-11-14 Oreal Fraction ribosomale et composition la contenant
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
FR2790959B1 (fr) * 1999-03-15 2003-06-27 Pf Medicament Utilisation de fractions membranaires bacteriennes a effet adjuvant, leurs procedes de preparation et composition pharmaceutique les contenant
FR2790960B1 (fr) * 1999-03-15 2002-10-31 Pf Medicament Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
FR2790961B1 (fr) * 1999-03-17 2001-06-22 Fabre Pierre Sante Utilisation d'une composition comprenant des proteoglycanes de klebsiella pneumoniae, et des ribosomes ou des arn ribosomaux bacteriens pour le traitement et/ou la prevention des maladies parodontales
GB9927493D0 (en) * 1999-11-19 2000-01-19 Boc Group Plc Improved vacuum pumps
GB2370838A (en) 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
JP7167576B2 (ja) * 2018-09-14 2022-11-09 株式会社島津製作所 分析用試料の調製方法、分析方法および微生物の識別方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (enrdf_load_stackoverflow) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2305990A1 (fr) * 1975-04-02 1976-10-29 Fabre Sa Pierre Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens
FR2360314A2 (fr) * 1976-08-06 1978-03-03 Fabre Sa Pierre Nouveaux vaccins perfectionnes a base de fractions ribosomales
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process

Also Published As

Publication number Publication date
GR3005567T3 (enrdf_load_stackoverflow) 1993-06-07
DE3780843D1 (de) 1992-09-10
FR2596064A1 (fr) 1987-09-25
EP0238407A1 (fr) 1987-09-23
ES2051759T3 (es) 1994-07-01
EP0238407B1 (fr) 1992-08-05
FR2596064B1 (fr) 1990-02-02
JPH01124396A (ja) 1989-05-17
ATE79037T1 (de) 1992-08-15
DE3780843T2 (de) 1992-12-24

Similar Documents

Publication Publication Date Title
AU6270286A (en) Therapeutic nucleosides
AU7009387A (en) Membrane proteoglycans ribosomal vaccines
DE69320176D1 (de) Peptidylderivate und inhibitoren des interleukin-1-g(b)-konvertierenden enzyms
GB2211068B (en) Bacterial treatment to preserve hay quality by addition of microorganisms of the genus bacillus
ES8707724A1 (es) Un procedimiento para preparar laudanos
AU617318B2 (en) Outer membrane protein f of pseudomonas aeruginosa
AU585216B2 (en) Process for the microbiological preparation of l-carnitine
IL113595A0 (en) Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
AU2158688A (en) Use of bezafibrate for treating diabetes
DK125887A (da) Beskyttelse af heste mod streptococcus equi
BR8108073A (pt) Sequencias de dna;plasmidios recombinantes;cultura bacteriana;e processo para a producao de preprotaumatina,pretaumatina ou protaumatina
HUT63845A (en) Polyhydroxycyclopentane derivatives, their production and use in therapy
AU1958988A (en) Process for the treatment of hides
NO885777D0 (no) Fremgangsmaate for rensing av granulocytt/makrofagkoloniistimulerende faktor.
AU3905893A (en) Plant resistant to two or more viruses and preparation thereof
EP0234494A3 (en) Isohexide nucleosides, processes for their preparation and their use as medicaments
NZ220303A (en) Cheesemaking; milk inoculated with bacterial protoplasts
AU7066287A (en) Pharmaceutical compositions containing 5-phenyl-1, 3-dioxoalkenyl compounds
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours
AU586809B2 (en) Process for the preparation of a germ free solution of a lactose-splitting enzyme and its use.
EP0189587A3 (en) Method of sterilizing recombinant microorganism
ZA815094B (en) Novel peptide
ES2028464T3 (es) Un procedimiento para preparar una silice de precipitacion.
SU1367487A1 (ru) Способ получения антирабической вакцины
ES2000294A6 (es) Procedimiento de obtener polimeros de antocianosidos de la uva